ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
암 진단 시장의 규모는 최근 급속히 확대하고 있습니다. 2025년 255억 달러에서 2026년에는 285억 8,000만 달러로, CAGR 12.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 전 세계 암 발병률 상승, 종양학 조사에 대한 투자 증가, 병원 진단 인프라 확충, 영상 진단 기반 암 검출법 보급 확대, 검사실 자동화 발전 등이 요인으로 꼽힙니다.
암 진단 시장 규모는 향후 수년간 급성장이 전망되고 있습니다. 2030년에는 446억 9,000만 달러에 달하며, CAGR은 11.8%에 달할 전망입니다. 예측 기간 중의 성장에는 개인 맞춤형 암 치료에 대한 수요 증가, 차세대 시퀀싱 진단의 보급 확대, 인구 전체를 대상으로 한 암 검진 프로그램 확대, AI를 활용한 종양 진단에 대한 투자 확대, 다중 암 검출 검사에 대한 지속적인 기술 혁신 등이 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 분자진단 및 동반진단의 채택 확대, 암 진단에 AI의 통합 증가, 바이오마커 기반 검사 활용 확대, 고처리량 진단 플랫폼의 확대, 조기 암 검진에 대한 집중 강화 등이 있습니다.
향후 수년간 의료비 지출 증가가 암 진단 시장의 성장을 촉진할 것으로 예측됩니다. 의료비 지출은 정부, 기업, 개인이 의료 시술, 입원 치료, 의약품, 공중 보건 조치에 할당하는 총 자금을 의미합니다. 의료비 지출에 대한 수요 증가는 주로 장기적이고 고가의 치료가 필요한 만성질환의 유병률 증가에 의해 주도되고 있습니다. 의료비 지출 증가는 첨단 검진 기술의 도입을 가능하게 하고, 조기 발견 서비스에 대한 접근성을 확대하여 암 진단을 지원합니다. 현대식 장비와 전문 검사실에 대한 투자는 진단 정확도를 높이고, 적시에 개입할 수 있게 하며, 환자의 치료 결과를 향상시킵니다. 예를 들어 2024년 5월 영국 통계청이 발표한 데이터에 따르면 2023년 의료 총 지출은 명목상 5.6% 증가하여 2022년 대비 0.9% 상승할 것으로 예상했습니다. 따라서 의료비 지출 증가는 암 진단 시장의 성장을 가속하고 있습니다.
폐암 발생률 증가도 암 진단 시장을 촉진하는 중요한 요인입니다. 폐암은 폐 조직에 비정상적인 세포가 비정상적으로 증식하여 종양을 형성하고 다른 부위로 전이되는 질환입니다. 암 진단 기기는 폐암의 발견, 진단, 경과 관찰에 필수적이며, 의료진이 암의 유무, 유형, 병기를 판단하고 치료 방침을 결정하는 데 중요한 역할을 합니다. 예를 들어 2023년 3월 미국 임상종양학회(ASCO)는 2023년 미국에서 23만 8,340명이 폐암 진단을 받을 것으로 추산했습니다. 이는 2022년 236,000건에서 증가한 수치입니다. 따라서 폐암 발생률 증가는 암 진단 시장의 확대에 기여하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 방글라데시 시장
제19장 태국 시장
제20장 베트남 시장
제21장 말레이시아 시장
제22장 싱가포르 시장
제23장 필리핀 시장
제24장 홍콩 시장
제25장 뉴질랜드 시장
제26장 대만 시장
제27장 동남아시아 시장
제28장 서유럽 시장
제29장 영국 시장
제30장 독일 시장
제31장 프랑스 시장
제32장 이탈리아 시장
제33장 스페인 시장
제34장 오스트리아 시장
제35장 벨기에 시장
제36장 덴마크 시장
제37장 핀란드 시장
제38장 아일랜드 시장
제39장 네덜란드 시장
제40장 노르웨이 시장
제41장 포르투갈 시장
제42장 스웨덴 시장
제42장 스위스 시장
제43장 동유럽 시장
제44장 러시아 시장
제45장 체코 시장
제46장 폴란드 시장
제47장 루마니아 시장
제48장 우크라이나 시장
제49장 북미 시장
제50장 미국 시장
제51장 캐나다 시장
제52장 멕시코 시장
제53장 남미 시장
제54장 브라질 시장
제55장 칠레 시장
제56장 아르헨티나 시장
제57장 콜롬비아 시장
제58장 페루 시장
제59장 중동 시장
제60장 사우디아라비아 시장
제61장 이스라엘 시장
제62장 이란 시장
제63장 튀르키예 시장
제64장 아랍에미리트 시장
제65장 아프리카 시장
제66장 이집트 시장
제67장 나이지리아 시장
제68장 남아프리카공화국 시장
제69장 시장 규제 상황과 투자환경
제70장 경쟁 구도와 기업 개요
제71장 기타 대기업과 혁신적 기업
제72장 세계의 시장 경쟁 벤치마킹과 대시보드
제73장 주요 합병과 인수
제74장 시장의 잠재력이 높은 국가, 부문, 전략
제75장 부록
KSA
영문 목차
영문목차
Cancer diagnostics involves the processes, tests, and technologies used to detect the presence of cancer in individuals. This area includes various methods aimed at identifying, staging, and characterizing cancer, enabling timely and effective treatment.
The primary offerings within the cancer diagnostics sector include companion diagnostics and molecular diagnostics. Molecular diagnostics involve laboratory procedures to detect particular proteins, genes, or molecules indicating the presence of cancer. Diagnostic methods in cancer assessments encompass biopsies, endoscopies, tumor biomarker tests, and imaging. These diagnostic tools cater to various applications, including cervical cancer, breast cancer, liver cancer, blood cancer, kidney cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and others. They are utilized by diverse end-users like cancer research institutes, diagnostic laboratories, hospitals, and related entities.
Tariffs are influencing the cancer diagnostics market by increasing costs of imported sequencing platforms, imaging systems, reagents, consumables, and laboratory automation equipment. Hospitals, diagnostic laboratories, and research institutes in North America and Europe are most affected due to heavy reliance on imported diagnostic technologies, while Asia-Pacific faces higher procurement costs for advanced testing platforms. These tariffs are raising testing costs and slowing laboratory expansion plans. At the same time, they are encouraging regional manufacturing of diagnostic kits, localized reagent production, and increased focus on cost-efficient diagnostic innovation.
The cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides cancer diagnostics market statistics, including cancer diagnostics industry global market size, regional shares, competitors with a cancer diagnostics market share, detailed cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cancer diagnostics industry. This cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cancer diagnostics market size has grown rapidly in recent years. It will grow from $25.5 billion in 2025 to $28.58 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to rising global cancer prevalence, increased investments in oncology research, expansion of hospital diagnostic infrastructure, growing adoption of imaging-based cancer detection, improvements in laboratory automation.
The cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $44.69 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing demand for personalized cancer therapies, rising adoption of next-generation sequencing diagnostics, expansion of population-wide cancer screening programs, growing investments in AI-enabled oncology diagnostics, continuous innovation in multi-cancer detection tests. Major trends in the forecast period include increasing adoption of molecular and companion diagnostics, rising integration of ai in cancer detection, growing use of biomarker-based testing, expansion of high-throughput diagnostic platforms, enhanced focus on early cancer screening.
Rising healthcare expenditure is expected to drive growth in the cancer diagnostics market in the coming years. Healthcare expenditure encompasses the total financial resources allocated to medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. The growing demand for healthcare spending is largely driven by the increasing prevalence of chronic diseases, which require long-term and often costly care. Higher healthcare expenditure supports cancer diagnostics by enabling the adoption of advanced screening technologies and expanding access to early detection services. Investments in modern equipment and specialized laboratories enhance diagnostic accuracy, facilitate timely intervention, and improve patient outcomes. For example, in May 2024, the UK Office for National Statistics reported that total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing a 0.9% rise compared to 2022. Therefore, rising healthcare expenditure is fueling the growth of the cancer diagnostics market.
The increasing incidence of lung cancer is another key factor driving the cancer diagnostics market. Lung cancer originates in the lung tissues, where abnormal cells grow uncontrollably, forming tumors that may spread to other parts of the body. Cancer diagnostic devices are essential for detecting, diagnosing, and monitoring lung cancer, helping healthcare professionals determine its presence, type, stage, and guide treatment decisions. For instance, in March 2023, the American Society of Clinical Oncology (ASCO), a US-based organization, estimated that 238,340 people in the United States would be diagnosed with lung cancer in 2023, up from 236,000 cases in 2022. Therefore, the rising incidence of lung cancer is contributing to the expansion of the cancer diagnostics market.
Major companies operating in the cancer diagnostics market are focusing on artificial intelligence (AI)-driven innovations to improve diagnostic precision and efficiency. AI-based tools analyze tissue samples and clinical data to aid pathologists in identifying cancerous and non-cancerous regions. For example, in March 2023, Qritive, a Singapore-based developer of AI-powered diagnostic solutions, launched QAi Prostate. This advanced AI-powered tool assists in prostate cancer diagnosis by using machine learning algorithms to accurately detect and classify malignant and benign areas in prostate tissue samples, supporting pathologists in making informed diagnostic and treatment decisions.
Major companies operating in the cancer diagnostics market are Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Biogenex Laboratories, Veracyte, PathAI, Bio-Rad Laboratories, BioChain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, Invitae Corporation, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics
North America was the largest region in the cancer diagnostics market in 2025. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cancer diagnostics market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cancer diagnostics market consists of sales of pathology-based instruments (slide staining systems, tissue processing systems, cell processors, PCR instruments, NGS instruments, and other pathology-based instruments), imaging Instruments (CT systems, ultrasound systems, MRI systems, mammography systems, and nuclear imaging systems) and biopsy instruments that are used for the diagnosis of cancer. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cancer Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Products: Companion Diagnostics; Molecular Diagnostics
2) By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging
3) By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma; Other Applications
4) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End Users
Subsegments:
1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics; Genetic Testing-Based Companion Diagnostics; Immunohistochemistry-Based Companion Diagnostics; PCR-Based Companion Diagnostics; Other Companion Diagnostics;
2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics; Next-Generation Sequencing (NGS) Diagnostics; In Situ Hybridization Diagnostics; Microarray-Based Diagnostics; DNA Or RNA Extraction Kits; Other Molecular Diagnostics
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Biotechnology, Genomics & Precision Medicine
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of Molecular And Companion Diagnostics
4.2.2 Rising Integration Of Ai In Cancer Detection
4.2.3 Growing Use Of Biomarker-Based Testing
4.2.4 Expansion Of High-Throughput Diagnostic Platforms
4.2.5 Enhanced Focus On Early Cancer Screening
5. Cancer Diagnostics Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Diagnostic Laboratories
5.3 Cancer Research Institutes
5.4 Specialty Oncology Centers
5.5 Academic Medical Institutions
6. Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Cancer Diagnostics Market Segmentation
9.1. Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Companion Diagnostics, Molecular Diagnostics
9.2. Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging
9.3. Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications
9.4. Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users
9.5. Global Cancer Diagnostics Market, Sub-Segmentation Of Companion Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Cancer Diagnostics Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics
10. Cancer Diagnostics Market Regional And Country Analysis
10.1. Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Cancer Diagnostics Market
11.1. Asia-Pacific Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Cancer Diagnostics Market
12.1. China Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Cancer Diagnostics Market
13.1. India Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Cancer Diagnostics Market
14.1. Japan Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Cancer Diagnostics Market
15.1. Australia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Cancer Diagnostics Market
16.1. Indonesia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Cancer Diagnostics Market
17.1. South Korea Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Bangladesh Cancer Diagnostics Market
18.1. Bangladesh Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Thailand Cancer Diagnostics Market
19.1. Thailand Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Vietnam Cancer Diagnostics Market
20.1. Vietnam Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Malaysia Cancer Diagnostics Market
21.1. Malaysia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Singapore Cancer Diagnostics Market
22.1. Singapore Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. Philippines Cancer Diagnostics Market
23.1. Philippines Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Hong Kong Cancer Diagnostics Market
24.1. Hong Kong Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. New Zealand Cancer Diagnostics Market
25.1. New Zealand Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Taiwan Cancer Diagnostics Market
26.1. Taiwan Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Taiwan Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. South East Asia Cancer Diagnostics Market
27.1. South East Asia Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. South East Asia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Western Europe Cancer Diagnostics Market
28.1. Western Europe Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. Western Europe Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. UK Cancer Diagnostics Market
29.1. UK Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Germany Cancer Diagnostics Market
30.1. Germany Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. France Cancer Diagnostics Market
31.1. France Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Italy Cancer Diagnostics Market
32.1. Italy Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Spain Cancer Diagnostics Market
33.1. Spain Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Austria Cancer Diagnostics Market
34.1. Austria Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Belgium Cancer Diagnostics Market
35.1. Belgium Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
36. Denmark Cancer Diagnostics Market
36.1. Denmark Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
37. Finland Cancer Diagnostics Market
37.1. Finland Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
38. Ireland Cancer Diagnostics Market
38.1. Ireland Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
39. Netherlands Cancer Diagnostics Market
39.1. Netherlands Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
40. Norway Cancer Diagnostics Market
40.1. Norway Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
41. Portugal Cancer Diagnostics Market
41.1. Portugal Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
42. Sweden Cancer Diagnostics Market
42.1. Sweden Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
42. Switzerland Cancer Diagnostics Market
42.1. Switzerland Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
43. Eastern Europe Cancer Diagnostics Market
43.1. Eastern Europe Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
43.2. Eastern Europe Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
44. Russia Cancer Diagnostics Market
44.1. Russia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
45. Czech Republic Cancer Diagnostics Market
45.1. Czech Republic Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
46. Poland Cancer Diagnostics Market
46.1. Poland Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
47. Romania Cancer Diagnostics Market
47.1. Romania Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
48. Ukraine Cancer Diagnostics Market
48.1. Ukraine Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
49. North America Cancer Diagnostics Market
49.1. North America Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
49.2. North America Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
50. USA Cancer Diagnostics Market
50.1. USA Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
50.2. USA Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
51. Canada Cancer Diagnostics Market
51.1. Canada Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
51.2. Canada Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
52. Mexico Cancer Diagnostics Market
52.1. Mexico Cancer Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
52.2. Mexico Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
53. South America Cancer Diagnostics Market
53.1. South America Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
53.2. South America Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
54. Brazil Cancer Diagnostics Market
54.1. Brazil Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
55. Chile Cancer Diagnostics Market
55.1. Chile Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
56. Argentina Cancer Diagnostics Market
56.1. Argentina Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
57. Colombia Cancer Diagnostics Market
57.1. Colombia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
58. Peru Cancer Diagnostics Market
58.1. Peru Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
59. Middle East Cancer Diagnostics Market
59.1. Middle East Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
59.2. Middle East Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
60. Saudi Arabia Cancer Diagnostics Market
60.1. Saudi Arabia Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
61. Israel Cancer Diagnostics Market
61.1. Israel Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
62. Iran Cancer Diagnostics Market
62.1. Iran Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
63. Turkey Cancer Diagnostics Market
63.1. Turkey Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
64. United Arab Emirates Cancer Diagnostics Market
64.1. United Arab Emirates Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
65. Africa Cancer Diagnostics Market
65.1. Africa Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
65.2. Africa Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
66. Egypt Cancer Diagnostics Market
66.1. Egypt Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
67. Nigeria Cancer Diagnostics Market
67.1. Nigeria Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
68. South Africa Cancer Diagnostics Market
68.1. South Africa Cancer Diagnostics Market, Segmentation By Products, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
69. Cancer Diagnostics Market Regulatory and Investment Landscape
70. Cancer Diagnostics Market Competitive Landscape And Company Profiles
70.1. Cancer Diagnostics Market Competitive Landscape And Market Share 2024
70.1.1. Top 10 Companies (Ranked by revenue/share)
70.2. Cancer Diagnostics Market - Company Scoring Matrix
70.2.1. Market Revenues
70.2.2. Product Innovation Score
70.2.3. Brand Recognition
70.3. Cancer Diagnostics Market Company Profiles
70.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
70.3.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
70.3.3. Hologic Overview, Products and Services, Strategy and Financial Analysis
70.3.4. GE Healthcare Ltd. Overview, Products and Services, Strategy and Financial Analysis
70.3.5. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
71. Cancer Diagnostics Market Other Major And Innovative Companies
